MUSL — Promino Nutritional Sciences Income Statement
0.000.00%
Last trade - 00:00- CA$8.80m
- CA$10.83m
- CA$2.15m
Annual income statement for Promino Nutritional Sciences, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2.36 | 4 | 0.478 | 0.261 | 2.15 |
| Cost of Revenue | |||||
| Gross Profit | 0.175 | -0.508 | 0.256 | -0.343 | 0.449 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 12.4 | 14.4 | 5.55 | 6.85 | 4.38 |
| Operating Profit | -10.1 | -10.4 | -5.07 | -6.59 | -2.23 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -8.78 | -10.3 | -5.81 | -7.07 | -2.99 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -8.78 | -10.3 | -5.81 | -7.07 | -2.99 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -8.78 | -10.3 | -5.81 | -7.07 | -2.99 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -8.78 | -10.3 | -5.81 | -7.07 | -2.99 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.101 | -0.091 | -0.125 | -0.086 | -0.029 |